New evidence suggests that low concentrations of testosterone are associated with an increased risk of cardiovascular disease in men.
Read More »Issue 164 Item 7 Glargine Vs. NPH In Combo With Oral Treatment In Type 2’s
Glargine showed fewer episodes of nocturnal hypoglycemia.
Read More »Issue 164 Item 8 Rosiglitazone Improves Insulin Sensitivity, Glucose Control and
Rosiglitazone improves insulin sensitivity and glucose control, while lowering circulating vascular/inflammatory markers.
Read More »ssue 164 Item 9 Late-Breaking Clinical Trial Results of the Carvedilol Vs. Metop
Carvedilol is Associated With A Significant Survival Benefit Over Metoprolol
Read More »Issue 164 Item 10 Pre-diabetes’ Raises Risk of Dying from Cancer
Having too much insulin in the blood may promote cancer production.
Read More »Issue 164 Item 11 Fish Insulin Discovery A Breakthrough In Diabetes Treatment
Scientists here have zeroed in on a new source of insulin in fish that mimics human insulin more closely than any known animal source — porcine or bovine — currently in use.
Read More »Issue 164 Item 12 Diabetes More Common in Snorers, Problem Sleepers
Pre-diabetes and diabetes occur more frequently in people who snore or who have a sleep disorder called sleep apnea
Read More »Issue 164 Item 13 Intensive Glycemic Control Pays Interest Before and After Reti
According to a new analysis from DCCT, intensive glycemic control is associated with reduced coronary calcification, a marker of atherosclerosis, years later — even if control has become less intense in the interim.
Read More »Issue 164 Item 14 Drug for Treating Type-2 Diabetes May Limit Heart Disease Risk
Rosiglitazone, may be a good choice for patients with type 2-diabetes who require additional medications to prevent heart attacks.
Read More »Issue 164 Item 15 Obesity Increases Risk for Death from Cancer
Researchers conclude that as many as 14% of cancer deaths in men and 20% of cancer deaths in women may be attributable to excess weight.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.